These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31884374)

  • 1. Complexity changes in preclinical Alzheimer's disease: An MEG study of subjective cognitive decline and mild cognitive impairment.
    Shumbayawonda E; López-Sanz D; Bruña R; Serrano N; Fernández A; Maestú F; Abasolo D
    Clin Neurophysiol; 2020 Feb; 131(2):437-445. PubMed ID: 31884374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network Disruption in the Preclinical Stages of Alzheimer's Disease: From Subjective Cognitive Decline to Mild Cognitive Impairment.
    López-Sanz D; Garcés P; Álvarez B; Delgado-Losada ML; López-Higes R; Maestú F
    Int J Neural Syst; 2017 Dec; 27(8):1750041. PubMed ID: 28958179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatiotemporal Oscillatory Patterns During Working Memory Maintenance in Mild Cognitive Impairment and Subjective Cognitive Decline.
    Serrano N; López-Sanz D; Bruña R; Garcés P; Rodríguez-Rojo IC; Marcos A; Crespo DP; Maestú F
    Int J Neural Syst; 2020 Jan; 30(1):1950019. PubMed ID: 31522594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oscillatory Activity of the Hippocampus in Prodromal Alzheimer's Disease: A Source-Space Magnetoencephalography Study.
    Luppi JJ; Schoonhoven DN; van Nifterick AM; Gouw AA; Hillebrand A; Scheltens P; Stam CJ; de Haan W
    J Alzheimers Dis; 2022; 87(1):317-333. PubMed ID: 35311705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment and Comparison of Nonlinear Measures in Resting-State Magnetoencephalograms in Alzheimer's Disease and Mild Cognitive Impairment.
    Azami H; Daftarifard E; Humeau-Heurtier A; Fernandez A; Abasolo D; Rajji TK
    J Alzheimers Dis; 2023; 96(3):1151-1162. PubMed ID: 37980661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexity analysis of spontaneous brain activity in Alzheimer disease and mild cognitive impairment: an MEG study.
    Fernández A; Hornero R; Gómez C; Turrero A; Gil-Gregorio P; Matías-Santos J; Ortiz T
    Alzheimer Dis Assoc Disord; 2010; 24(2):182-9. PubMed ID: 20505435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural markers of reduced arousal and consciousness in mild cognitive impairment.
    Estarellas M; Huntley J; Bor D
    Int J Geriatr Psychiatry; 2024 Jun; 39(6):e6112. PubMed ID: 38837281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological brain signatures for the classification of subjective cognitive decline: towards an individual detection in the preclinical stages of dementia.
    López-Sanz D; Bruña R; Delgado-Losada ML; López-Higes R; Marcos-Dolado A; Maestú F; Walter S
    Alzheimers Res Ther; 2019 Jun; 11(1):49. PubMed ID: 31151467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha band disruption in the AD-continuum starts in the Subjective Cognitive Decline stage: a MEG study.
    López-Sanz D; Bruña R; Garcés P; Camara C; Serrano N; Rodríguez-Rojo IC; Delgado ML; Montenegro M; López-Higes R; Yus M; Maestú F
    Sci Rep; 2016 Nov; 6():37685. PubMed ID: 27883082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing the fluctuations of dynamic resting-state electrophysiological functional connectivity: reduced neuronal coupling variability in mild cognitive impairment and dementia due to Alzheimer's disease.
    Núñez P; Poza J; Gómez C; Rodríguez-González V; Hillebrand A; Tola-Arribas MA; Cano M; Hornero R
    J Neural Eng; 2019 Sep; 16(5):056030. PubMed ID: 31112938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study.
    Bessi V; Mazzeo S; Bagnoli S; Padiglioni S; Carraro M; Piaceri I; Bracco L; Sorbi S; Nacmias B
    Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):471-482. PubMed ID: 31560105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological and neurophysiological characterization of mild cognitive impairment and Alzheimer's disease in Down syndrome.
    García-Alba J; Ramírez-Toraño F; Esteba-Castillo S; Bruña R; Moldenhauer F; Novell R; Romero-Medina V; Maestú F; Fernández A
    Neurobiol Aging; 2019 Dec; 84():70-79. PubMed ID: 31518951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective Spatial Navigation Complaints - A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease.
    Cerman J; Andel R; Laczo J; Vyhnalek M; Nedelska Z; Mokrisova I; Sheardova K; Hort J
    Curr Alzheimer Res; 2018; 15(3):219-228. PubMed ID: 29165083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of spontaneous MEG activity in mild cognitive impairment and Alzheimer's disease using spectral entropies and statistical complexity measures.
    Bruña R; Poza J; Gómez C; García M; Fernández A; Hornero R
    J Neural Eng; 2012 Jun; 9(3):036007. PubMed ID: 22571870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spontaneous electroencephalographic and magneto-encephalographic activity as a marker of Alzheimer's disease and mild cognitive impairment].
    Fernández A; Gil Gregorio P; Maestú F
    Rev Esp Geriatr Gerontol; 2012; 47(1):27-32. PubMed ID: 22099881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subjective Cognitive Decline in Preclinical Alzheimer's Disease.
    Rabin LA; Smart CM; Amariglio RE
    Annu Rev Clin Psychol; 2017 May; 13():369-396. PubMed ID: 28482688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.
    Kuhn E; Moulinet I; Perrotin A; La Joie R; Landeau B; Tomadesso C; Bejanin A; Sherif S; De La Sayette V; Desgranges B; Vivien D; Poisnel G; Chételat G
    Alzheimers Res Ther; 2019 Jul; 11(1):61. PubMed ID: 31286994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEG spectral profile in Alzheimer's disease and mild cognitive impairment.
    Fernández A; Hornero R; Mayo A; Poza J; Gil-Gregorio P; Ortiz T
    Clin Neurophysiol; 2006 Feb; 117(2):306-14. PubMed ID: 16386951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of odors, faces, cities and naming of objects in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer´s disease: a longitudinal study.
    Tahmasebi R; Zehetmayer S; Pusswald G; Kovacs G; Stögmann E; Lehrner J
    Int Psychogeriatr; 2019 Apr; 31(4):537-549. PubMed ID: 30236169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease based on multicenter diffusion tensor imaging.
    Brueggen K; Dyrba M; Cardenas-Blanco A; Schneider A; Fliessbach K; Buerger K; Janowitz D; Peters O; Menne F; Priller J; Spruth E; Wiltfang J; Vukovich R; Laske C; Buchmann M; Wagner M; Röske S; Spottke A; Rudolph J; Metzger CD; Kilimann I; Dobisch L; Düzel E; Jessen F; Teipel SJ;
    J Neurol; 2019 Oct; 266(10):2465-2474. PubMed ID: 31227891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.